New Studies
Major findings from Lancet, BMJ, NEJM, JAMA, and other leading journals
Sitafloxacin monotherapy matches doxycycline-rifampicin for brucellosis treatment in landmark trial
A multicenter randomized trial in The Lancet Regional Health – Western Pacific found that sitafloxacin monotherapy is non-inferior to standard…
Editor's Top Picks
Ethiopia Study Reveals Stakeholder Concerns Over Novel Malaria Treatments
A qualitative study in Ethiopia reveals that health workers and patients view shorter-course malaria treatments as promising but harbour significant…
Submit Your Paper →
More form New Studies
How one biotech startup transformed clinical trial failure into an AI-powered health technology breakthrough
A biotech startup has converted data from a failed clinical trial into an artificial intelligence…
The Hidden Cost of Secrecy: How Missing Research Data Undermines Clinical Guidance
Systematic reviews and meta-analyses that guide clinical practice are increasingly compromised by lack of access…
Corrected Global Data on Substance Use Burden Across 204 Countries Reveals Shifting Patterns
Nature Medicine has published a corrected Global Burden of Disease assessment of substance use disorders…
Engineered Heart Muscle From Stem Cells Shows Promise in First-in-Human Trial
A first-in-human clinical trial of engineered heart muscle derived from induced pluripotent stem cells has…
Semaglutide Linked to Fewer Bone Fractures Despite Greater Weight Loss in Type 2 Diabetes
A real-world analysis of 60,000 adults with type 2 diabetes shows semaglutide users experienced 15%…